Company

Ratio Therapeutics

Biotechnology Research 1 Design Center Pl 64 employees

Employees: 64
Contacts: 4
Emails: 4
Phones: 4

ratiotx.com LinkedIn Crunchbase

Ratio Therapeutics Overview

Headquarters: 1 Design Center Pl
Website: ratiotx.com
Industry: Biotechnology Research
Employees: 64
Founded: 2021
Funding: 50.0M
NAICS: Research and Development in Biotechnology (except Nanobiotechnology)

Keywords

will be a valuable asset as we continue to advance our radiopharmaceutical pipeline.

About Ratio Therapeutics

A discovery through early clinical phase pharmaceutical company, Ratio Therapeutics employs a suite of innovative technologies to develop best-in-class targeted radiotherapeutics for the treatment of cancer. Ratio Therapeutics’ Trillium™ targeting scaffold combines pharmacokinetic modulation with best-in-class chelation technology to create proprietary small molecule targeting agents to attack a broad array of cancer targets. Our compounds accommodate imaging and therapeutic radioisotopes, ie "theranostics". The tunable nature of our platform combined with small-scale imaging trials in patients results in accelerated, de-risked compound selection.

Ratio Therapeutics Contact Details

People in AeroLeads: 4
With contact data: 4
Email contacts: 4; 100.0% coverage
Phone contacts: 4; 100.0% coverage

Ratio Therapeutics Org Chart

Sample employees and titles

Name	Title	Location	Contact
Christine Redmond	Executive Leadership - Drug	Westford, Massachusetts, United States	Email Phone
Steve Kreis	Director of Software Engineering	Greater Binghamton, United States	Email Phone
John Garvey	General Counsel at Ratio Therapeutics	Boston, Massachusetts, United States	Email Phone
Jacob Hesterman	Chief Data Officer, Ratio Therapeutics	United States	Email Phone